低剂量的电击和心房动.
1Imperial Cardiac Center, Imperial, California.
Advanced emergency nursing journal
|October 27, 2023
概括
电击可以导致严重的心脏问题,即使是来自低压损伤. 本案例研究强调了心房动是电击后的关键并发症,强调了电击患者心脏评估的必要性.
科学领域:
- 紧急医疗 紧急医疗
- 心脏病学 心脏病学
- 毒理学 毒理学 毒理学
背景情况:
- 电击事件导致各种伤害,从轻微到致命.
- 心脏并发症,特别是心律失常,是电击幸存者死亡的重要原因,即使暴露在低电压中.
- 目前的管理指南建议将电伤患者治疗为创伤和心脏病例,并根据个体情况进行量身定制的诊断.
研究的目的:
- 介绍一篇关于电击事件后心房动的案例研究.
- 讨论与电损伤相关的常见心律失常.
- 为了强调心脏评估对电击受害者的重要性.
主要方法:
- 案例报告的呈现方式.
- 对有关电击伤害和心脏并发症的相关医学文献的审查.
- 对患者表现和诊断结果的分析.
主要成果:
- 该案例研究详细介绍了一名在电击事件后患有心房动的患者.
- 在电力损伤中观察到的常见心律失常包括导电障碍和心肌损伤.
- 由于心脏并发症,低压损伤带来了更高的死亡风险.
结论:
- 心房动是电击的一个显著并发症.
- 由于潜在的心律失常,电损伤需要全面的心脏评估.
- 个性化诊断方法对于治疗电动创伤患者至关重要.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
22
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
22
Disturbances in Heart Rhythm
977
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
977
Dysrhythmias VI: Management of Dysrhythmias
17
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
17
Electroconvulsive Therapy
47
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
47
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


